Vimarsana
Biggest News Aggregation in the World

Page 27 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Study Today - Breaking & Trending Today

Migraine Experts: Head-to-Head Drug Comparisons Better - Vimarsana News

Migraine Experts: Head-to-Head Drug Comparisons Better

Placebo-controlled trials are insufficient for decisions that affect medication availability in EU member states.

Where Is the 'Microbiome Revolution' Headed Next? - Vimarsana News

Where Is the 'Microbiome Revolution' Headed Next?

Famed microbiome researcher Dr Martin J. Blaser shares what he sees as the most promising applications, and the rigorous clinical trials needed to realize them.

New Multiple Myeloma Staging Systems Outperform the Standard - Vimarsana News

New Multiple Myeloma Staging Systems Outperform the Standard

Findings from a large US cohort study show comparable accuracy, but better discrimination of patients across disease stages.

Concerns Over Nalmefene Nasal Spray for Opioid Overdose - Vimarsana News

Concerns Over Nalmefene Nasal Spray for Opioid Overdose

Experts urge rigorous research due to safety concerns and uncertainties and prefer naloxone as the preferred first-line agent.

Disease Control Elusive for Many Patients on AD Therapies - Vimarsana News

Disease Control Elusive for Many Patients on AD Therapies

A significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia."